ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Brigid Levental, Pediatric researcher, Dead At 58

February 18, 1994